Global
Stocks
As the AI-Driven Rally Slows Down… Global Capital Flows into Chinese Biotech
Global capital has recently been flowing into Chinese biotech companies. As the AI rally in global Shinhung stock markets has slowed, investors seeking high-growth alternatives are turning their atten…
- 2026-07-27 10:30:44
- KIM JUNG YOU
Manufacturing
"Driven by PDRN, a New Growth Engine Derived from Ultra-Nano Probiotics, the Company Aims to Double Sales This Year and Return to Profit Next Year" [In-Depth Look at AccuGen ③]
AccuGen is accelerating its expansion into new bio-material businesses, including cosmetic and health functional food ingredients based on polydeoxyribonucleotide (PDRN) derived from lactic acid bacte…
- 2026-07-27 08:11:08
- SHIN MIN JOON
Manufacturing
"Strengths in One-Stop Comprehensive Microbial Services, from AI Analysis to the Development, Production, and Delivery of Consumables" [In-Depth Look at AccuGen ②]
AccuGen is the only company in Korea to offer a one-stop comprehensive service that encompasses microbial analysis as well as the development, production, and delivery of consumables. AccuGen also hol…
- 2026-07-27 08:11:08
- SHIN MIN JOON
Manufacturing
"Leaping from Genetic Testing and Medical Device Consumables to a Natural Microbial Materials Company" [In-Depth Look at AccuGen ①]
"We will transform AccuGen from a company specializing in genetic sample collection tubes and kits, as well as next-generation sequencing (NGS) microbiome testing, into a leading provider of natural m…
- 2026-07-27 08:11:02
- SHIN MIN JOON
Manufacturing
"From Product Introduction to Joint Venture Establishment"... HANDOK Inc. Sees Full Effect of Its Dual-Pronged Strategy for Cancer and Rare Diseases
Mid-sized pharmaceutical company HANDOK Inc.(002390)is continuing its trend of improved performance, driven by its dual focus on anticancer drugs and treatments for rare diseases. HANDOK Inc. has trad…
- 2026-07-26 09:31:01
- SHIN MIN JOON
Culture (Global)
Musk, Who Has Been Taking Shots at Nolan Day After Day, Says, "I'll Remake 'Odyssey' Using AI"
Elon Musk, CEO of Tesla and SpaceX, has unveiled plans to produce a feature-length film titled “Odyssey” using generative artificial intelligence (AI). He has recently been publicly critical of the ca…
- 2026-07-23 13:42:09
- YUN GI BACK
Commodities
While Samsung Electronics Retail Investors Cried, These Investors Laughed… The Truth Behind the 'Unconventional Investment' That Hit the Jackpot [Market In]
Amid increased volatility in the domestic stock market, driven primarily by major semiconductor stocks, an unconventional investment product focused on coffee beans is drawing attention. This comes as…
- 2026-07-21 18:28:04
- KIM YEON-SEO
Manufacturing
GL Pharm Tech Corp. Obtains Marketing Approval for “Telmieltan,” the First Generic Version of the Hypertension Drug Telminuvo
GL Pharm Tech Corp.(204840)announced that its subsidiary, GL Pharma, has obtained marketing authorization from the Ministry of Food and Drug Safety for the antihypertensive combination drug Telmieltan…
- 2026-07-21 14:13:02
- SHIN MIN JOON
Culture (Global)
Morocco to Invest 76 Trillion to Expand Accommodation Capacity by 20% Ahead of the 2030 World Cup
Morocco, which will co-host the 2030 FIFA World Cup with Spain and Portugal, is embarking on a massive investment initiative to transform its national infrastructure. The country plans to increase hot…
- 2026-07-21 08:00:33
- Kang Gyeong-rok
IT
iA, Inc. to Jointly Develop Korean-Style AI Server with KTNF
iA, Inc.(038880)and its subsidiary, iA, Inc., are partnering with domestic server manufacturer KTNF to jointly develop Korean-made AI servers and small-scale data centers. Through this initiative, the…
- 2026-07-20 15:39:01
- Kwon so hyun
PHARM EDAILY
Shorts